FollowTheFilings

Managers Activity Compare Newest

Investment

MOONLAKE IMMUNOTHERAPEUTICS

Historical 13F holders

CUSIP: 61559X104
Type: Equity
Class: CLASS A ORD

Period	13F filings
2026 Q1	7
2025 Q4	9
2025 Q3	9
2025 Q2	5
2025 Q1	6
2024 Q4	6
2024 Q3	5

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.